PTGS2 and cancer: Cyclooxygenase-2 overexpression has been reported in various human cancers and is associated with poor prognosis in colon carcinoma, pulmonary carcinoma, breast carcinoma, malignant mesothelioma, squamous cell carcinoma, and chronic myelogenous leukemia [14–18].